期刊文献+

破骨细胞分化因子和护骨素mRNA在OVX小鼠骨组织的相对表达 被引量:8

The relative expression of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA in bone tissue in ovariectomized mice
原文传递
导出
摘要 目的 研究破骨细胞分化因子 (ODF)和护骨素 (OPG)mRNA在OVX小鼠骨组织中的相对表达水平 ,探讨ODF和OPG在绝经后骨质疏松 (PMO)发病中的意义。 方法 将 4 0只小鼠随机分为 5组 ,第Ⅰ、Ⅴ组行假手术 ,两组小鼠分别在术后 1周和 5周处死 ;第Ⅱ、Ⅲ组行卵巢切除手术 ,分别在术后 1周和 5周处死 ;Ⅳ组行卵巢切除手术 ,术后第 2天给苯甲酸雌二醇治疗 ,5周后处死。小鼠处死后 ,提取其骨组织总RNA ,RT PCR检测ODF和OPGmRNA表达水平。 结果 去卵巢后Ⅱ、Ⅲ、Ⅳ组ODF与OPGmRNA比值 (分别为 1 16 78± 0 2 873、0 80 93± 0 14 14、0 6 6 4 0± 0 0 935 )显著增高 ,采用雌激素防治可使其一定程度上恢复。 Objective To investigate the expression and regulation of ODF and OPG in vivo in ovariectomized mice. Methods Forty female mice at six weeks of age were allocated into 5 groups, 8 in each. Group Ⅱ, Ⅲ and Ⅳ were ovariectomized. Group Ⅳ were subcutaneously injected with Benzoic estradiol for 5 weeks one day after the ovariectomy. Group Ⅱ and Ⅲ were given placebo instead and sacrificed 1 and 5 weeks after the ovariectomy respectively. Group Ⅰ and Ⅴ were sham-operated and treated with placebo, then sacrificed 1 and 5 weeks respectively after ovariectomy. The tibia and femur were dissected out and mRNA levels of ODF and OPG were studied using reverse transcription polymerase chain reaction technique. Results The mRNA level of ODF was elevated by ovariectomy while that of OPG was reduced at one week while increased 5 weeks after ovariectomy, which seemed a compensation for the acceleration of bone loss. As a consequence, the ratio of ODF to OPG mRNA (ODF/OPG) was elevated by ovariectomy while reduced significantly when benzoic estradiol was supplemented. Conclusions It indicates that OVX-induced bone loss might be associated with the disturbance of ODF/OPG.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2003年第10期608-611,共4页 Chinese Journal of Geriatrics
基金 国家自然科学基金项目 (3 0 2 7115 4)
关键词 破骨细胞分化因子 护骨素 MRNA OVX小鼠 骨组织 相对表达 骨质疏松 绝经后 Osteoclasts NF-kappa B Osteoporosis, postmenopausal
  • 相关文献

参考文献13

  • 1郭若霖,郭善一,鲍秋野,张镜宇.竞争性RT-PCR测定法及BMP-2mRNA的定量检测[J].中国生物化学与分子生物学报,2000,16(5):680-683. 被引量:11
  • 2王宝利,邱明才.白细胞介素-6与绝经后骨质疏松[J].中华老年医学杂志,2001,20(1):73-75. 被引量:6
  • 3Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 1998, 93: 165-176.
  • 4Burgess TL, Qian Y, Kaufman S, et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol, 1999, 145: 527-538.
  • 5Hofbauer LC, Khosla S, Dunstan CR, et al. Estrogen stimulate gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology,1999,140: 4367-4370.
  • 6Nemeth GG, Heydemann A, Bolander ME. Isolation and analysis of ribonucleic acids from skeletal tissues. Anal Biochem, 1989, 183: 301-304.
  • 7Kurebayashi S, Miyashita Y, Hirose T, et al. Characterization of mechanisms of IL-6 gene repression by estrogen receptor. J Steroid Biochem Mol Biol, 1997, 60:11-17.
  • 8Kimble RB, Bain S, Pacifici R, et al. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res, 1997, 12: 935-941.
  • 9Mieko Saika, Daisuke Inoue, Shinsuke Kido, et al. 17 beta-estradiol stimulates expression of osteoprotegerin by a mouses tromal cell line, ST2, via estragen receptor-α. Endocrinology, 2001, 142: 2205-2212.
  • 10Liao EY, Luo XH, Su X. Comparison of the effects of 17 beta-E2 and progesterone on the expression of osteoprotegerin in normal human osteoblast-like cells. J Endoerinol Invest,2002, 25: 785-790.

二级参考文献17

  • 1宋学文,赵崇,邓彤,蔡军,何炜,张镜宇.大鼠脑谷氨酸脱羧酶基因的cDNA克隆及序列分析[J].生物化学杂志,1996,12(5):544-546. 被引量:3
  • 2Sambrook j Fritsch EF.分子克隆实验指南(第2版)[M].北京:科学出版社,1992..
  • 3金冬雁(译),分子克隆实验指南(第2版),1992年,956页
  • 4Wang A M,Proc Nat Acad Sci SUA,1989年,86卷,9717页
  • 5Sun W H,Biochem Biophys Res Commun,1998年,244卷,691页
  • 6Kimble R B,J Bone Miner Res,1997年,12卷,935页
  • 7Langub M C,Kidney Int,1996年,50卷,515页
  • 8Kimble R B,J Bone Miner Res,1995年,10卷,suppl 1期,S160页
  • 9Sato T,J Bone Miner Res,1995年,10卷,s225页
  • 10Udagawa N,J Exp Med,1995年,1461页

共引文献15

同被引文献62

  • 1王宝利,邱明才,郭刚,梁东春,张镜宇.小鼠骨保护素配基胞外片段的表达、纯化及生物活性分析(英文)[J].Acta Genetica Sinica,2004,31(7):675-681. 被引量:2
  • 2王宝利,梁晖,戴芳,郭刚,张镜宇.重叠延伸PCR法在合成人骨保护素N端编码序列中的应用[J].天津医科大学学报,2004,10(3):343-345. 被引量:15
  • 3姚静,钱存忠,张皎,张建峰,侯加法.鸡胚破骨细胞的分离培养与鉴定[J].南京农业大学学报,2005,28(3):88-91. 被引量:7
  • 4马超,黄思扬,蒋琳,杨福军,王革,辛芳.绿脓杆菌外毒素A与Ⅱ型单纯疱疹病毒糖蛋白嵌合表达质粒的构建及其免疫原性的研究[J].兰州大学学报(自然科学版),2005,41(5):48-51. 被引量:2
  • 5李丁 苏海种 等.骨组织总RNA的提取[J].第四军医大学学报,1999,20(12):1056-1056.
  • 6Lacey D L,Timms E,Tan H L,Kelley M J,Dunstan C R,Burgess T,Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N,Davy E, Capparelli C, Eli A, Qian Y x, Kaufman S, Sarosi I,Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 1998,93(2): 165 ~ 176
  • 7Haynes D R, Barg E, Crotti T N, Holding C, Weedon H, Atkins G J,Zannetino A,Ahern M J, Coleman M, Roberts-Thomson P J, Kraan M,Tak P P, Smith M D. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritids and normal controls. Rheumatology, 2003,42 ( 1 ): 123 ~134
  • 8Nakashima T, Wada T, Penninger J M. RANKL and RANK as novel therapeutic targets for arthritis. Curr Opin Rheumatol, 2003,15 (3): 280~ 287
  • 9Kostenuik P J, Capparelli C, Morony S, Adamu S, Shimamoto G, Shen V,Lacey D L,Dunstan C R.OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats.Endocrinology, 2001,142(10) :4295 ~ 4304
  • 10Schett G, Redlich K, Hayer S, Zwerina J, Bolon B, Dunstan C, Gortz B,Schulz A, Bergmeister H, Kollias G, Steiner G, Smolen J S.Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum, 2003,48 (7): 2042 ~ 2051

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部